Wholesale QSC Tirzepatide LY 3298176 Diabetes Research Chemical

QSC tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This synthetic peptide demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.

The qsc tirzepatide compound exhibits preferential binding affinity for GIP receptors while maintaining significant activity at GLP-1 receptors. This unique dual mechanism of action has shown promising results in preclinical studies for metabolic disorder research.

Our qsc tirzepatide is supplied as a lyophilized white powder with purity exceeding 98% (typically >99%) as verified by HPLC analysis. The product is carefully packaged to ensure stability and delivered with comprehensive analytical documentation.

As a research chemical, qsc tirzepatide is intended for laboratory use only by qualified professionals. This product is not for human consumption or diagnostic use.